Bridgewater Bancshares (NASDAQ: BWB) insider details option exercise, share sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bridgewater Bancshares’ president and CFO reported changes in his ownership of the company’s common stock.
On 12/10/2025, he exercised 6,000 stock options at $7.47 per share and acquired the same number of shares, and also sold 5,211 shares at a weighted average price of $18.049.
After these transactions, he beneficially owns 105,349 shares directly and 1,000 shares indirectly through a spouse’s IRA, and continues to hold multiple stock option awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,211 shares ($94,053)
Net Sell
7 txns
Insider
Chybowski Joseph M.
Role
PRESIDENT & CFO
Sold
5,211 shs ($94K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to buy | 6,000 | $0.00 | -- |
| Exercise | Common Stock | 6,000 | $7.47 | $45K |
| Sale | Common Stock | 5,211 | $18.049 | $94K |
| holding | Option to buy | -- | -- | -- |
| holding | Option to buy | -- | -- | -- |
| holding | Option to buy | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Option to buy — 136,500 shares (Direct);
Common Stock — 110,560 shares (Direct);
Common Stock — 1,000 shares (Indirect, By Spouse IRA)
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.035 to $18.049, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4. Options to buy granted under the 2012 Combined Incentive and Non-Statutory Stock Option Plan. Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017. Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan. Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019. Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022.